System-based approaches as prognostic tools for glioblastoma
Abstract Background The evasion of apoptosis is a hallmark of cancer. Understanding this process holistically and overcoming apoptosis resistance is a goal of many research teams in order to develop better treatment options for cancer patients. Efforts are also ongoing to personalize the treatment o...
Main Authors: | Manuela Salvucci, Zaitun Zakaria, Steven Carberry, Amanda Tivnan, Volker Seifert, Donat Kögel, Brona M. Murphy, Jochen H. M. Prehn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-6280-2 |
Similar Items
-
Inhibition of Multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
by: Amanda eTivnan, et al.
Published: (2015-06-01) -
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma
by: Wang QW, et al.
Published: (2020-01-01) -
Distinguishing Glioblastoma Subtypes by Methylation Signatures
by: Yu-Hang Zhang, et al.
Published: (2020-11-01) -
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
by: Xiaomeng Li, et al.
Published: (2021-02-01) -
An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
by: Marta Calvo Tardón, et al.
Published: (2020-09-01)